Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydergine for dementia.

J Olin1, L Schneider, A Novit

  • 1Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, KAM-400, Los Angeles, CA, 90033, USA. jolin@hsc.usc.edu

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance and nutrient composition of black soldier fly larvae fed diets with various protein concentrations throughout the life cycle.

Animal : an international journal of animal bioscience·2025
Same author

Uptake of drug-reduced antiretroviral strategies and impact on costs over 2015-22: experience from an HIV clinic in Paris, France.

The Journal of antimicrobial chemotherapy·2025
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

No virological failure in patients living with HIV with past NNRTI resistance-associated mutations switched to doravirine-containing regimens.

The Journal of antimicrobial chemotherapy·2025
Same author

Knowledge, attitudes and practices on prevention and control of high-consequence infectious diseases and critical care among intensive care personnel in Rwanda: a cross-sectional survey.

Infection prevention in practice·2024
Same author

Extrahepatic Bile Duct Organoids as a Model to Study Ischemia/Reperfusion Injury During Liver Transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2024
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Hydergine (ergoloid mesylates) shows significant treatment effects for dementia symptoms, improving global and comprehensive ratings compared to placebo. However, the evidence for Alzheimer's disease is modest, and subgroup analyses were limited by trial data.

Area of Science:

  • Geriatric Medicine
  • Pharmacology
  • Clinical Trials

Background:

  • Hydergine is prescribed for dementia and age-related cognitive decline, but its efficacy remains debated due to inconsistent trial data and biased reviews.
  • Previous meta-analyses suggest hydergine is more effective than placebo, but with limited statistical power for specific conditions like Alzheimer's disease.

Purpose of the Study:

  • To assess the overall efficacy of hydergine in patients with possible dementia.
  • To identify potential factors moderating hydergine's treatment effect.

Main Methods:

  • A systematic search of multiple databases (Cochrane Dementia Group Register, MEDLINE, EMBASE) identified relevant randomized, double-blind, placebo-controlled trials.
  • Data from 19 trials were extracted and analyzed using pooled odds ratios and average differences, focusing on global and comprehensive rating scales.

Related Experiment Videos

  • Potential moderators including age, dose, and diagnostic group were investigated.

    • Main Results:

    • Hydergine demonstrated significant treatment effects compared to placebo on both global ratings (OR 3.78, 95%CI 2.72-5.27) and comprehensive rating scales (WMD 0.96, 95%CI 0.54-1.37).
    • The drug was well-tolerated, with high subject retention rates.
    • Larger effect sizes on global ratings were associated with younger age and possibly higher doses, though these findings were not always statistically significant.

    Conclusions:

    • Hydergine exhibits statistically significant treatment effects in patients with dementia, consistent across global and comprehensive outcome measures.
    • The limited number of trials and available data restricted the power of subgroup analyses to identify significant moderators of treatment effect.
    • Further research with robust data is needed to fully elucidate hydergine's efficacy and identify optimal patient subgroups.